Inventor · disambiguated record
Christian Rommel
Also filed as: ROMMEL CHRISTIAN
19 granted patents·22 pending applications·291 citations·filing 2002–2025
95Inventor score
Top patents by PatentIndex Score
41 records- 0198US8569323B2Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereofREN PINGDA·Filed 2012·Granted Oct 29, 2013·61 cites·14 claims
- 0298US8193182B2Substituted isoquinolin-1(2H)-ones, and methods of use thereofREN PINGDA·Filed 2009·Granted Jun 5, 2012·93 cites·39 claims
- 0396US8785456B2Substituted isoquinolin-1(2H)-ones, and methods of use thereofREN PINGDA·Filed 2012·Granted Jul 22, 2014·25 cites·170 claims
- 0496US8703777B2Certain chemical entities, compositions and methodsREN PINGDA·Filed 2009·Granted Apr 22, 2014·36 cites·35 claims
- 0594US9522146B2Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereofINTELLIKINE LLC·Filed 2015·Granted Dec 20, 2016·10 cites·24 claims
- 0691US9669032B2Enhanced treatment regimens using mTOR inhibitorsINTELLIKINE LLC·Filed 2015·Granted Jun 6, 2017·13 cites·17 claims
- 0791US9629843B2MTOR modulators and uses thereofUNIV CALIFORNIA·Filed 2015·Granted Apr 25, 2017·18 cites·1 claims
- 0891US9216982B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2014·Granted Dec 22, 2015·8 cites·28 claims
- 0990US9206182B2Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereofINTELLIKINE LLC·Filed 2013·Granted Dec 8, 2015·8 cites·27 claims
- 1087US2024209000A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2023·Application pending·0 cites
- 1185US9174994B2Enhanced treatment regimens using mTor inhibitorsINTELLIKINE LLC·Filed 2012·Granted Nov 3, 2015·9 cites·21 claims
- 1281US9682141B2Combination of kinase inhibitors and uses thereofINTELLIKINE LLC·Filed 2012·Granted Jun 20, 2017·5 cites·4 claims
- 1381US9295673B2Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereofREN PINGDA·Filed 2012·Granted Mar 29, 2016·4 cites·1 claims
- 1480US2022265637A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2021·Application pending·0 cites
- 1580US2025170122A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2025·Application pending·0 cites
- 1678US9655892B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2015·Granted May 23, 2017·1 cites·21 claims
- 1777US11433065B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2019·Granted Sep 6, 2022·0 cites·16 claims
- 1874US2022372048A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2020·Application pending·0 cites
- 1971US2019290636A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2018·Application pending·0 cites
- 2067US2018098983A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2017·Application pending·0 cites
- 2165US2017281614A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2016·Application pending·0 cites
- 2264US2018258103A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2017·Application pending·0 cites
- 2364US2014206684A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2014·Application pending·0 cites
- 2461US9822131B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2016·Granted Nov 21, 2017·0 cites·10 claims
- 2560US10172858B2Combination pharmaceutical compositions and uses thereofINTELLIKINE LLC·Filed 2016·Granted Jan 8, 2019·0 cites·8 claims
- 2657US2015087627A1Combination of kinase inhibitors and uses thereofINTELLIKINE LLC·Filed 2014·Application pending·0 cites
- 2756US2014357651A1Combination pharmaceutical compositions and uses thereofLIU YI·Filed 2012·Application pending·0 cites
- 2856US2011224223A1MTOR Modulators and Uses ThereofUNIV CALIFORNIA CORP·Filed 2009·Application pending·0 cites
- 2955US10399731B2Cluster pack comprising containers having a reinforced wall sectionKHS GMBH·Filed 2015·Granted Sep 3, 2019·0 cites·20 claims
- 3053US2011269779A1Methods and compositions for treatment of ophthalmic conditionsINTELLIKINE INC·Filed 2009·Application pending·0 cites
- 3153US2016089371A1Combination of Kinase Inhibitors and Uses ThereofINTELLIKINE LLC·Filed 2014·Application pending·0 cites
- 3252US2014377285A1Treatment regimens using multiple pharmaceutical agentsINTELLIKINE LLC·Filed 2012·Application pending·0 cites
- 3350US2005205690A1Holder for sample elements of, in particular for card samplesSILFOX HOLDING GMBH·Filed 2003·Application pending·0 cites
- 3450US2017209448A1Treatment regimens using multiple pharmaceutical agentsINTELLIKINE LLC·Filed 2017·Application pending·0 cites
- 3549US2016235758A1Combination of mtor inhibitors and pi3-kinase inhibitors, and uses thereofINTELLIKINE LLC·Filed 2016·Application pending·0 cites
- 3648US2016287597A1Treatment Regimens Using Multiple Pharmaceutical AgentsINTELLIKINE LLC·Filed 2016·Application pending·0 cites
- 3744US2014066462A1Treatment of polycystic diseaseINTELLIKINE LLC·Filed 2013·Application pending·0 cites
- 3842US10414085B2Container and blow moldKHS CORPOPLAST GMBH·Filed 2016·Granted Sep 17, 2019·0 cites·19 claims
- 3939US7157239B2Method and kit for identifying and/or quantifying radiolabeled aminoglycoside binding moleculesAPPLIED RESEARCH SYSTEMS·Filed 2002·Granted Jan 2, 2007·0 cites·18 claims
- 4039US2008039377A1Composition Comprising a Jnk Inhibitor and CyclosporinAPPLIED RESEARCH SYSTEMS·Filed 2005·Application pending·0 cites
- 4128US2009042773A1P13 kinase gamma inhibitors for the treatment of anaemiaWETZKER REINHARD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian Rommel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →